Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Nordion sheds its targeted therapy business and the TheraSphere targeted liver cancer therapy to BTG plc for $200 million.
Covidien begins enrollment in a pair of clinical studies evaluating its Stellarex drug-coated angioplasty balloon in the U.S. and abroad.
1. Newsmakers and game changers at the MassDevice Big 100 East 2013
MassDevice.com saw a record-breaking turnout at this year’s Big 100 East event in Waltham, Mass., which lured nearly 300 top executives together to talk leadership strategies, challenges and the future of the industry.